Despite the opinion split amongst medics on the value of cannabis, there are a growing number of products on the market that contain cannabis extracts.
These have all been developed by leading pharmaceutical companies to treat a wide range of conditions – from nausea to Multiple Sclerosis.
On first sight, you may think these products on the market are treading a path for a more widespread cannabis usage in medicine. If Pharma is giving the green light, then surely widespread opinion will be sure to change?
However, the more sceptical of us could argue that pharmaceutical companies are just developing synthetic and less effective forms of cannabis compounds to make money on a drug that might not even be that successful.
What’s wrong with inhaling or consuming the real thing? Not much – but in the areas where medical marijuana is still illegal, the following drugs are the nearest things that some patients can get without breaking the law – and cost a whole lot more.
Will the pharmaceuticals close in on the cannabis industry? For such a natural product, it is hard to see how this could work, but certainly one could argue that these corporations are following the money. Medical marijuana is extremely powerful – and therefore very much in demand. If people need it to cure ills, then it’s only a matter of time until these types of products flood the market.
Or maybe I’m just an old cynic. Whatever the future is, here are ten products available, or in development right now.
Probably one of the most well know cannabis-based pharma products out there, Sativex was developed to relieve neuropathic pain and spasticity in patients with MS. The mouth spray was developed in the UK by GW Pharmaceutics and contain a balance of THC and CBD.
Marinol pills contain a synthetic form of THC. These pills are given to cancer patients reduce nausea and vomiting as a side effect of chemotherapy. Marinol can also be prescribed to patients suffering from AIDS and can stimulate the appetite.
Another product which contains only synthesised and not real strains of THC. These capsules work in a similar way to Marinol and relieve nausea and vomiting – as well as kickstart appetites in AIDS patients.
These capsules of synthetic cannabis are used in to protect the brain after cardiac surgery by blocking the NMDA receptors, COX-2 cytokines and chemokines. They are non-psychotropic and help to regain memory after traumatic brain injury.
CT-3 or Ajulemic acid
CT-3 contains a synthetic form of THC metabolite called THC-11-oic acid. While this drug has not yet been approved, there has been clinical success in treating neuropathic pain in patients suffering with MS. It may also help arthiritic patients with its anti-inflammatory properties.
Cannabinor is another drug contain a synthetic chemical which binds to the brain’s secondary cannabinoid receptor in the brain. This has been developed for hypertension and has currently not been approved.
This drug – another not yet approved – that has been developed to suppress appetites by blocking endocannabinoid receptors from stimulating hunger signals.
This is another anti-cannabinoid drug that has been designed to block cannabinoids from sending hunger signals.
HU331 is a synthetic product which is designed to bind to the cannabinoid receptors in the brain. This non-approved drug was developed to treat appetite problems, weight loss, analgesia, neurodegeneration and inflammation.
Like HU331 above, this cannabis product has been developed to bind to the cannabinoid receptors in the brain. Like HU331, it is a synthetic form of cannabis, and has also not been approved for use – it is still in its early days of development. It is supposed to help hypertension and anti-inflammation.